Treatment of Fungal Blepharitis, Conjunctivitis, and Keratitis

NATACYN® is the first and only FDA approved ophthalmic anti-fungal with over 40 years of proven safety and efficacy. With over 27 countries relying on NATACYN® to treat fungal infections caused by susceptible organisms including Fusarium solani the World Health Organization (WHO) has placed NATACYN® on the Essential Medicines list.

 

Eyevance® Pharmaceuticals LLC has been acquired by Santen Pharmaceutical Co., Ltd. Natacyn® is a registered trademark of Eyevance Pharmaceuticals.

INDICATIONS AND USAGE
NATACYN® (natamycin ophthalmic suspension) 5% is indicated for the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis.

IMPORTANT SAFETY INFORMATION
ADVERSE REACTIONS
The following events have been identified during post-marketing use of NATACYN® in clinical practice: allergic reaction, change in vision, chest pain, corneal opacity, dyspnea, eye discomfort, eye edema, eye hyperemia, eye irritation, eye pain, foreign body sensation, paresthesia, and tearing.

Please see the Full Prescribing Information.

Global Research & Development
Copyright © 2023 Santen Pharmaceutical Co., Ltd.
All Rights Reserved